sparfloxacin has been researched along with Leprosy in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chehl, SK; Gelber, RH; Murray, LP; Richard, V; Siu, P; Tsang, M | 1 |
Gidoh, M; Hidaka, T; Matsuki, G; Nakamura, S; Tsutsumi, S | 1 |
Banerjee, DK; McDermott-Lancaster, RD | 1 |
Chan, GP; Franzblau, SG; Parrilla, ML | 1 |
Ishii, N; Nakajima, H; Sato, I; Sugita, Y | 1 |
Kashiwabara, Y; Matsuoka, M; Namisato, M | 1 |
Gelber, RH; Iranmanesh, A; Murray, L; Siu, P; Tsang, M | 1 |
Grosset, JH; Ji, B; Perani, EG; Petinon, C | 1 |
1 trial(s) available for sparfloxacin and Leprosy
Article | Year |
---|---|
Sparfloxacin in the treatment of leprosy patients.
Topics: Adult; Anti-Infective Agents; Biopsy; Fluoroquinolones; Follow-Up Studies; Humans; Leprosy; Male; Quinolones; Retrospective Studies; Skin; Treatment Outcome | 1997 |
7 other study(ies) available for sparfloxacin and Leprosy
Article | Year |
---|---|
Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Topics: Animals; Anti-Infective Agents; Clarithromycin; Dapsone; Drug Therapy, Combination; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Minocycline; Quinolones; Rifampin | 1995 |
Inhibition of the multiplication of Mycobacterium leprae in nude mice by intermittent administration of a new rifamycin derivative, 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin (KRM-1648) combined with sparfloxacin.
Topics: Administration, Oral; Animals; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Leprostatic Agents; Leprosy; Mice; Mice, Inbred BALB C; Mice, Nude; Mycobacterium leprae; Quinolones; Rifamycins | 1995 |
Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Fluoroquinolones; Leprosy; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Quinolones | 1993 |
Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
Topics: Animals; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Ofloxacin; Quinolones | 1993 |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
Topics: Animals; Anti-Infective Agents; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Pefloxacin; Quinolones | 1992 |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin | 1992 |